These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9613859)

  • 1. Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2).
    Smith AC; Dykens E; Greenberg F
    Am J Med Genet; 1998 Mar; 81(2):179-85. PubMed ID: 9613859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).
    Gropman AL; Duncan WC; Smith AC
    Pediatr Neurol; 2006 May; 34(5):337-50. PubMed ID: 16647992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).
    Smith AC; Dykens E; Greenberg F
    Am J Med Genet; 1998 Mar; 81(2):186-91. PubMed ID: 9613860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Speech impairment and the Smith-Magenis syndrome].
    Bergmann C; Morlot S; Ptok M
    HNO; 2007 Aug; 55(8):644-6. PubMed ID: 16767429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and adaptive behavior profiles in Smith-Magenis syndrome.
    Madduri N; Peters SU; Voigt RG; Llorente AM; Lupski JR; Potocki L
    J Dev Behav Pediatr; 2006 Jun; 27(3):188-92. PubMed ID: 16775514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuropsychiatry and multisystem features of the Smith-Magenis syndrome: a review.
    Shelley BP; Robertson MM
    J Neuropsychiatry Clin Neurosci; 2005; 17(1):91-7. PubMed ID: 15746488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2).
    Greenberg F; Guzzetta V; Montes de Oca-Luna R; Magenis RE; Smith AC; Richter SF; Kondo I; Dobyns WB; Patel PI; Lupski JR
    Am J Hum Genet; 1991 Dec; 49(6):1207-18. PubMed ID: 1746552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse.
    Bi W; Yan J; Stankiewicz P; Park SS; Walz K; Boerkoel CF; Potocki L; Shaffer LG; Devriendt K; Nowaczyk MJ; Inoue K; Lupski JR
    Genome Res; 2002 May; 12(5):713-28. PubMed ID: 11997338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smith-Magenis syndrome: Clinical and behavioral characteristics in a large retrospective cohort.
    Rive Le Gouard N; Jacquinet A; Ruaud L; Deleersnyder H; Ageorges F; Gallard J; Lacombe D; Odent S; Mikaty M; Manouvrier-Hanu S; Ghoumid J; Geneviève D; Lehman N; Philip N; Edery P; Héron D; Rastel C; Chancenotte S; Thauvin-Robinet C; Faivre L; Perrin L; Verloes A
    Clin Genet; 2021 Apr; 99(4):519-528. PubMed ID: 33368193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene for a human microfibril-associated glycoprotein is commonly deleted in Smith-Magenis syndrome patients.
    Zhao Z; Lee CC; Jiralerspong S; Juyal RC; Lu F; Baldini A; Greenberg F; Caskey CT; Patel PI
    Hum Mol Genet; 1995 Apr; 4(4):589-97. PubMed ID: 7633408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Turkish patient with large 17p11.2 deletion presenting with Smith Magenis syndrome.
    Tug E; Cine N; Aydin H
    Genet Couns; 2011; 22(1):11-9. PubMed ID: 21614983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smith-Magenis syndrome: report of one case.
    Hou JW
    Acta Paediatr Taiwan; 2003; 44(3):161-4. PubMed ID: 14521023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Smith-Magenis syndrome].
    Lacombe D; Moncla A; Malzac P; Mattei MG; Battin J
    Arch Pediatr; 1997 May; 4(5):438-42. PubMed ID: 9230994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions.
    Girirajan S; Elsas LJ; Devriendt K; Elsea SH
    J Med Genet; 2005 Nov; 42(11):820-8. PubMed ID: 15788730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refinement of the Smith-Magenis syndrome critical region to approximately 950kb and assessment of 17p11.2 deletions. Are all deletions created equally?
    Vlangos CN; Yim DK; Elsea SH
    Mol Genet Metab; 2003 Jun; 79(2):134-41. PubMed ID: 12809645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.
    Potocki L; Glaze D; Tan DX; Park SS; Kashork CD; Shaffer LG; Reiter RJ; Lupski JR
    J Med Genet; 2000 Jun; 37(6):428-33. PubMed ID: 10851253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum.
    Girirajan S; Vlangos CN; Szomju BB; Edelman E; Trevors CD; Dupuis L; Nezarati M; Bunyan DJ; Elsea SH
    Genet Med; 2006 Jul; 8(7):417-27. PubMed ID: 16845274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of risperidone treatment in Smith-Magenis syndrome (del 17 pll. 2).
    Niederhofer H
    Psychiatr Danub; 2007 Sep; 19(3):189-92. PubMed ID: 17914318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mosaicism for del(17)(p11.2p11.2) underlying the Smith-Magenis syndrome.
    Juyal RC; Kuwano A; Kondo I; Zara F; Baldini A; Patel PI
    Am J Med Genet; 1996 Dec; 66(2):193-6. PubMed ID: 8958329
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.